Conjugated linoleic acid modulation of risk factors associated with atherosclerosis

Nutrition and Metabolism

Volumn 5, Issue 1, 2008, Pages

  Nakamura, Yukiko K ^a   Flintoff Dye, Nichole ^a   Omaye, Stanley T ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; CATECHIN; CLARINOL; CLOFIBRATE; CONJUGATED LINOLEIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLACEBO; REACTIVE OXYGEN METABOLITE; RESVERATROL; ROFECOXIB; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG FORMULATION; DRUG MECHANISM; DRUG TOLERABILITY; ENDOTHELIAL DYSFUNCTION; ENTERITIS; ENZYME INHIBITION; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GENE INTERACTION; GENE TARGETING; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RESPONSE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIPID METABOLISM; LIVER FUNCTION; NONHUMAN; OBESITY; OXIDATIVE STRESS; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SIDE EFFECT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; UNSPECIFIED SIDE EFFECT;

ANIMALIA;

EID: 52649131808     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-5-22     Document Type: Review

References (166)

1. Conjugated linoleic acid induces lipid peroxidation in humans. S Basu A Smedman B Vessby, FEBS Letters 2000 468 33 36 10.1016/S0014-5793(00)01193-5 10683436
2. Effects of conjugated linoleic acid on the degradation and oxidation stability of model lipids during heating and illumination. JF Chen CY Tai YC Chen BH Chen, Food Chemistry 2001 72 199 206 10.1016/S0308-8146(00)00219-3
3. The effects of feeding conjugated linoleic acid (CLA) on rat growth performance, serum lipoproteins and subsequent lipid composition of selected rat tissues. B Szymczyk P Pisulewski W Szczurek P Hanczakowski, Journal of the Science of Food and Agriculture 2000 80 1553 1558 10.1002/1097-0010(200008)80: 10<1553::AID-JSFA650>3.0.CO;2-Z
4. Conjugated linoleic acid: a novel therapeutic nutrient? HM Roche E Noone A Nugent MJ Gibney, Nutrition Research Reviews 2001 14 173 187 10.1079/095442201108729187
5. Colonic anti-inflammatory mechanisms of conjugated linoleic acid. J Bassaganya-Riera R Hontecillas DC Beitz, Clinical Nutrition 2002 21 451 459 10.1054/clnu.2002.0594 12468364
6. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. MA Belury, Annual Review of Nutrition 2002 22 505 531 10.1146/annurev.nutr.22.021302.121842 12055356
7. The role of dairy products in supplying conjugated linoleic acid to man's diet: a review. RE Lawson AR Moss DI Givens, Nutrition Research Reviews 2001 14 153 172 10.1079/095442201108729178
8. Oxidative stability of conjugated linoleic acid isomers. L Yang LK Leung Y Huang Z Chen, Journal of Agricultural and Food Science 2000 48 3072 3076 10.1021/jf0003404
9. Biological effects of conjugated linoleic acids in health and disease. A Bhattacharya J Banu M Rahman J Causey G Fernandes, Journal of Nutritional Biochemistry 2006 17 789 810 10.1016/j.jnutbio.2006.02.009 16650752
10. The impact of fortification with conjugated linoleic acid (CLA) on the quality of fluid milk. W Campbell MA Drake DK Larick, Journal of Dairy Science 2003 86 43 51 12613847
11. Differential oxidation of individual dietary fatty acids in humans. JP DeLany MM Windhauser CM Champagne GA Bray, The American Journal of Clinical Nutrition 2000 72 905 911 11010930
12. Antioxidants and prevention of chronic diesese. JK Willcox SL Ash GL Catignani, Clinical Reviews in Food Science and Nutrition 2004 44 275 295 10.1080/10408690490468489
13. Modification of atherogenesis and heart disease by grape wine and tea polyphenols. M Dubick ST Omaye, Nutraceuticals Handbook Oxford, UK: CRC Press, Wildman R, 2001 235 260
14. In vitro study of LDL transport under pressurized (convective) conditions. LM Cancel A Fitting JMI Tarbell, American Journal of Physiology Heart and Circulatory Physiology 2007 293 H126 132 10.1152/ajpheart.01188.2006
15. Oxidized low density lipoprotein and innate immune receptors. YI Miller MK Chang CJ Binder PX Shaw JL Witztum, Current Opinion in Lipidology 2003 14 437 445 10.1097/00041433-200310000-00004 14501582
16. Macrophage differentiation to foam cells. P Shashkin B Dragulev K Ley, Current Pharmaceutical Design 2005 11 3061 3072 10.2174/1381612054865064 16178764
17. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influence of degree of oxidation and location of oxidized LDL. A Takei Y Huang MF Lopes-Vorella, Atherosclerosis 2001 154 79 86 10.1016/S0021-9150(00)00465-2 11137085
18. Minimally modified low density lipoprotein induce monocyte chemotactic protein a in human endothelial cells and smooth muscle cells. SD Cushing JA Berliner AJ Valente MC Territo M Navab F Parhami R Gerrity CJ Schwartz AM Fogelman, Proceedings of the National Academy of Sciences of the United States of America 1990 87 5134 5138 1695010 10.1073/pnas.87.13.5134
19. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. W Shi ME Haberland ML Jien DM Shih AJ Lusis, Circulation 2000 102 75 81 10880418
20. Effects of oxidized low-and high-density lipoproteins on gene expression of human macrophages. M Levula O Jaakkola M Luomala ST Nikkari T Lehtimaki, Scandinavian Journal of Clinical and Laboratory Investigation 2006 66 497 508 10.1080/00365510600836651
21. Conjugated linoleic acids have no effect on TNFalpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human arrtic endothelial cells. S Schleser R Ringseis K Eder, Atherosclerosis 2006 186 337 344 10.1016/j.atherosclerosis.2005.08.018 16219313
22. Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. Y Sawa Y Sugimoto T Ueki H Ishikawa A Sato T Nagato S Yoshida, Journal of Histochmistry and Cytochemistry 2007 55 721 733 10.1369/jhc.6A7171.2007
23. OxLDL-induced gene expression patterns in CASMC are mimicked in apoE-/- mice aortas. JL Reeve C Stenson-Cox A O'Doherty I Porn-Ares M Ares T O'Brien A Samali, Biochemical and Biophysical Research Communications 2007 356 681 686 10.1016/j.bbrc.2007.03.027
24. Modified LDLs induce proliferation-mediated death of human endothelial cells through the MAPK pathway. EO Apostolov AG Basnakian X Yin E Ok S Shah, American Journal of Physiology Heart and Circulatory Physiology 2007 292 H1836 1846 10.1152/ajpheart.01079.2006
25. Multiple role of reactive oxygen species in the arterial wall. C Napoli F de Nigris W Palinski, Journal of Cellular Biochemistry 2001 82 674 682 10.1002/jcb.1198 11500945
26. Oxidative stress and the vascular wall NADPH oxidases take center stage. JFJ Keaney, Circulation 2005 112 2585 2588 10.1161/CIRCULATIONAHA.105.578146 16246957
27. Oxidative stress and atherosclerosis. U Singh I Jialal, Pathophysiology 2006 13 129 142 10.1016/j.pathophys.2006.05.002 16757157
28. Role of NADPH 4 oxidase in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. HS Park JN Chun HY Jung C Choi YS Bae, Cardiovascular Research 2006 72 447 455 10.1016/j.cardiores.2006.09.012 17064675
29. Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation. B Fuhrman M Shiner N Volkova M Aviram, Free Radical Biology and Medicine 2004 37 259 271 10.1016/j.freeradbiomed.2004.04.026
30. The role of PPARs in atherosclerosis. C Duval G Chinetti F Trottein JC Frunchart B Staels, Trends in Molecular Medicine 2002 8 422 430 10.1016/S1471-4914(02)02385-7 12223313
31. Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. BJ Hawkins M Madesh CJ Kirkpatrick AB Fisher, Molecular Biology of the Cell 2007 18 2002 2012 17360969 10.1091/mbc.E06-09-0830
32. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. DW Stepp J Ou AW Ackerman S Welak D Klick KAJ Pritchard, American Journal of Physiology Heart and Circulatory Physiology 2002 283 H750 759
33. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. TJ Guzik S Mussa D Gastaldi J Sadowski C Ratnatunga R Pillai KM Channon, Circulation 2002 105 1656 1662 10.1161/01.CIR.0000012748.58444.08 11940543
34. Atherosclerosis and the lectin-like oxidized low-density lipoprotein scavenger receptor. RS Vohra JE Murphy W JH S Ponnambalam S Homer-Vanniasinkam, Trends in Cardiovascular Medicine 2006 16 60 64 10.1016/j.tcm.2005.12.001 16473764
35. Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. XL Chen Q Zhang R Zhao RM Medford, American Journal of Physiology Heart and Circulatory Physiology 2004 286 H1001 1007 10.1152/ajpheart.00716.2003
36. Vascular C-reactive protein in the pathogeneisis of coronary artery disease: orle of vascular inflammation and oxidative stress. N Inoue, Cardiovascular and Hematological Diesorders Drug Targets 2006 6 227 231
37. Lipoxygenase-dependent superoxide release in skeletal muscle. L Zuo FL Christofi VP Wright S Bao TL Clanton, Journal of Applied Physiology 2004 97 661 668 10.1152/japplphysiol.00096.2004 15107407
38. Thromboxane mediates neutrophil superoxide production in pregnancy. JE Vaughan SW Walsh GD Ford, American Journal of Obestetrics and Gynecology 2006 195 1415 1420
39. Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. JY Im D Kim SG Paik PL Han, Free Radical Biology and Medicine 2006 41 960 972 10.1016/j.freeradbiomed.2006.06.001
40. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Z Xu S Choudhary O Voznesensky M Mehrotra M Woodard M Hansen H Herschman C Pilbeam, Cancer Research 2006 66 6657 6664 10.1158/0008-5472.CAN-05-3624 16818639
41. The biochemistry of n-3 polyunsaturated fatty acids. DB Jump, Journal of Biological Chemistry 2002 277 8755 8558 10.1074/jbc.R100062200 11748246
42. Lipid Biosynthesis. DL Nelson MM Cox, Lehninger Principles of Biochemistry New York, USA: Worth Publishers, Nelson DL, Cox MM, 3 2000 770 813
43. The cytochrome P450 4 (CPY4) family. AF Simpson, General Pharmacology 1997 28 351 359 9068972
44. Target organ toxicity and metabolic and biochemical responses following lung exposure. AK Reddy ST Omaye, Pulmonary Toxicology New York, USA: Marcel Dekker, Inc, Salem H, 1987 223 253
45. CD36, oxidized LDL and PPARgamma: pathological interactions in macrophages and atherosclerosis. AC Nicholson DP Hajjar, Vascular Pharmacology 2004 41 139 146 10.1016/j.vph.2004.08.003 15607497
46. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. D Kritchevsky SA Tepper S Wright SK Czarnecki TA Wilson RJ Nicolosi, Lipids 2004 39 611 616 10.1007/s11745-004-1273-8 15588017
47. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. D Kritchevsky SA Tepper S Wright P Tso SK Czarnecki, Journal of American College of Nutrition 2000 19 472S 477S
48. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. J Bassaganya-Riera R Hontecillas, Clinical Nutrition 2006 25 454 465 10.1016/j.clnu.2005.12.008 16698153
49. Activation of PPARgamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. J Bassaganya-Riera K Reynolds S Martino-Catt Y Cui L Hennighausen F Gonzalez J Rohrer AU Benninghoff R Hontecillas, Gastroenterology 2004 127 777 791 10.1053/j.gastro.2004.06.049 15362034
50. Vascular aging: Molecular modulation of the prostanoid cascade by calorie restriction. JW Kim Y Zou S Yoon JH Lee YK Kim BPC Yu Y H, The Journals of Gerontology, Series A, Biological Science and Medical Science 2004 59 B876 885
51. Peroxisome proliferator-activated alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition. Q Tian FA Grzemski S Panagiotopoulos JT Ahokas, Chemico-Biological Interactions 2006 160 241 251 10.1016/j.cbi.2006.02.003 16540100
52. Distribution of conjugated linoleic acid and metabolites in different lipid fractions in the rat liver. S Banni G Carta E Angioni E Murru P Scanu MP Melis DE Bauman SM Fischer C Ip, Journal of Lipid Research 2001 42 1056 1061 11441132
53. Evolutionarty aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. AP Simopoulos, Biomedicine and Phamacotherapy 2006 60 502 507 10.1016/j.biopha.2006.07.080
54. Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. LG Cleland MJ James MA Neumann M D'Angelo RA Gibson, The American Journals of Clinical Nutrition 1992 55 395 399
55. Fish consumptions, fish oil, omega-3 fatty acids, and cardiovascular disease. PM Kris-Etherton WS Harris LJ Appel American Heart Association Nutrition Committee, Circulation 2002 106 2747 2757 10.1161/01.CIR.0000038493. 65177.94 12438303
56. Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. M Hirafuji T Machida N Hamaue M Minami, Journal of Pharmacological Sciences 2003 92 308 316 10.1254/jphs.92.308 12939515
57. Essential fatty acids: biochemistry, physiology, and pathology. UN Das, Biotechnology Journal 2006 1 420 439 10.1002/biot.200600012 16892270
58. EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway. H Chen D Li GJ Roberts T Saldeen JL Mehta, Journal of Molecular and Cellular Cardiology 2003 35 769 775 10.1016/S0022-2828(03)00120-2 12818567
59. Fatty acid modulation of endothelial activation. R De Caterina JK Liao P Libby, The American Journal of Clinical Nutrition 2000 71 213S 223S 10617974
60. Inhibitory effects of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. ES Collie-Duguid KW Wahle, Biochemical and Biophysical Research Communications 1996 220 969 974 10.1006/bbrc.1996.0516 8607877
61. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. JY Lee DH Hwang, Molecules and Cells 2006 21 174 185
62. Antioxidant vitamins and cardiovascular disease. JM Gaziano, Proceedings of the Association of American Physicians 1999 111 2 9 10.1046/j.1525-1381.1999. 09229.x 9893151
63. Fruit and vegetable intake and risk of cardiovascular diesase: the Women's Health Study. S Liu JE Manson IM Lee SR Cole CH Hennekens WC Willett JE Buring, The American Journal of Clinical Nutrition 2000 72 899 900 11010927
64. Whole grain consumption and risk of ischemic stroke in women: A prospective study. S Liu JE Manson MJ Stampfer KM Rexrode FB Hu EB Rimm WC Willett, JAMA 2000 284 1534 1540 10.1001/jama.284.12.1534 11000647
65. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. LA Bazzano J He LG Ogden CM Loria S Vupputuri L Mvers PK Whelton, The American Journal of Clinical Nutrition 2002 76 93 99 12081821
66. Anti-atherosclerotic effects of alpha-tocopherol: myth or reality? A Munteanu JM Zingg A Azzi, Journal of Cellular and Molecular Medicine 2004 8 59 76 10.1111/j.1582-4934.2004.tb00260.x 15090261
67. The role of vitamin E in lipoprotein oxidation. H Esterbauer H Puhl G Waeg A Krebs M Dieber-Rotheneder, Vitamin E: Biochemistry and Clinical Application New York, USA: Marcel Dekker, Packer L, Fuchs J, 1992 649 671
68. Age-related changes of serum lipoprotein oxidation in rats. YK Nakamura ST Omaye, Life Sciences 2004 74 1265 1275 10.1016/j.lfs.2003.08.007 14697409
69. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). AC Carr B Zhu B Frei, Circulation Research 2000 87 349 354 10969031
70. Alpha -tocopherol, beta-carotene, and oxidative modification of human low-density lipoprotein. HT Bowen ST Omaye, Oxidant, Antioxidant and Free Radical Oxford, UK: Taylor and Francis, Baskin SI, Salem H, 1997 113 123
71. Oxidative changes associated with beta-carotene and alpha-tocopherol enrichment of human low-density lipoproteins. HT Bowen ST Omaye, Journal of American College of Nutrition 1998 17 171 179 9550461
72. Beta-carotene: Interactions with alpha-tocopherol and ascorbic acid in microsomal lipid peroxidation. P Zhang ST Omaye, Journal of Nutritional Biochemistry 2001 12 38 45 10.1016/S0955-2863(00)00143-1 11179860
73. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. UN Das N Maulik, Molecular Interventions 2006 6 36 47 10.1124/mi.6.1.7 16507749
74. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. B Frei JV Higdon, Journal of Nutrition 2003 133 3275S 3284S 14519826
75. Role of oxidative modifications in atherosclerosis. R Stocker JFJ Keaney, Physiological Review 2004 84 1381 1478 10.1152/physrev.00047.2003
76. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. GD Girnun FE Domann SA Moore MEC Robbins, Molecular Endocrinology 2002 16 2793 2801 10.1210/me.2002-0020 12456800
77. Incerased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. M Qiao M Kisgati JM Sholewa W Zhu EJ Smart MS Sulistio R Asmis, Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1375 1382 10.1161/ATVBAHA.107.142109 17363688
78. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. A Csiszar K Smith N Lavinskyy A Rivera Z Ungvari, American Journal of Physiology Heart and Circulatory Physiology 2006 291 H1694 1699 10.1152/ajpheart.00340.2006 16973825
79. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. J Hwang DJ Kleinhenz B Lassegue KK Griendling S Dikalov CM Hart, American Journal of Physiology, Cell Physiology 2005 288 C899 905 10.1152/ajpcell.00474.2004 15590897
80. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. X Fang NL Weintraub D Rios DA Chappell RM Zwacka JF Engelhardt LW Oberley T Yan DD Heistad AA Spector, Circulation Research 1998 82 1289 1297 9648725
81. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPAR gamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expression in primary endothelial cells. I Inoue S Goto T Matsunaga T Nakajima T Awara S Hokari T Komoda S Katayama, Metabolism 2001 50 3 11 10.1053/meta.2001.19415 11172467
82. Oxidative stress as a regulator of gene expression in the vasculature. C Kunsch RM Medford, Circulation Research 1999 85 753 766 10521248
83. NF-kappaB independent inhibition od lipopolysaccharide-induced cycloxygenase by a conjugated linoleic acid cognate, conjugated nonadecadienoic acid. G Li B Dong DE Butz Y Park MW Pariza ME Cook, Biochemica et Biophysica Acta 2006 1761 969 972
84. Conjugated linoleic acid isomers increases PPARgamma and NF-kappa B DNA binding activities in human umbilical vein endothelial cells: involvement of expression of Cu/Zn superoxide dismutase, catalse and lipid peroxidation. YK Nakamura ST Omaye, PhD thesis (in progress) University of Nevada, Reno, Environmental Sciences Graduate Program 2008
85. Dual role of oxidized LDL on the NF-kappaB signaling pathway. F Robbesyn R Salvayre A Negre-Salvayre, Free Radical Research 2004 38 541 551 10.1080/10715760410001665244 15346645
86. Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells. SA Vielma M Mironova JR Ku MF Lopes-Virella, Journal of Lipid Research 2004 45 873 880 10.1194/jlr.M300456- JLR200 14967815
87. The effects of TLR4/NF-kappaB activatioin and LOX-1 on monocyte adhesion to endothelium. HY Wang P Qu S Lu M Liu H Jiang, Zhonghua Xin Xue Guan Bing Za Zhi 2005 33 827 831 16266460
88. A source of energy, fat-soluble nutrients, and bioactive molecules. JB German CJ Dillard, Critical Reviews in Food Science and Nutrition 2007 46 57 92 10.1080/10408690590957098 16403683
89. The mechanisms of action of PPARs. J Berger DE Moller, Annual Review of Medicine 2002 53 409 435 10.1146/annurev.med.53.082901.104018 11818483
90. PPARgamma promotes monocyte/macorphage differentiation and uptake of oxidized LDL. P Tontonoz L Nagy JG Alvarez VA Thomazy RM Evans, Cell 1998 93 241 252 10.1016/S0092-8674(00)81575-5 9568716
91. Expression of the peroxisome proliferator-activate receptor gamma (PPARg) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoproteins. M Ricote J Huang L Fajas A Li J Welch J Najib JL Witztum J Auwerx W Palinski CK Glass, Proceedings of the National Academy of Sciences of the United States of America 1998 95 7614 7619 9636198 10.1073/pnas.95.13.7614
92. 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? WS Powell, The Journal of Clinical Investigation 2003 112 828 830 12975467
93. The peroxisome proliferator-activated receptor gamma is a negative regulator of macrophage activation. M Ricote AC Li TM Willson CJ Kelly CK Glass, Nature 1998 391 79 82 10.1038/34178 9422508
94. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. P Delerive K De Bosscher S Besnard W Vanden Berghe JM Peters FJ Gonzalez JC Frunchart A Tedgui G Haegeman B Staels, Journal of Biological Chemistry 1999 274 32048 32054 10.1074/jbc.274.45.32048 10542237
95. Dual roles for lipolysis and oixidation in peroxisome proliferator-activator receptor responses to electronegative lowdensity lipoprotein. O Ziouzenkova L Asatryan D Sahady G Orasanu S Perrey B Cutak T Hassell TE Akiyama JP Berger A Sevanian J Plutzky, The Journal of Biological Chemistry 2003 278 39874 39881 10.1074/jbc.M306786200 12878589
96. Nutrigenetics, plasma lipids, and cardiovascular risk. JM Ordovas, Journal of the American Dietetic Association 2006 106 1074 1081 10.1016/j.jada.2006.04.016 16815124
97. Polyunsaturated fatty acids modulate the effects of the APOA1G-A polymorphism on HDL-cholesterol concentrations in the sex-specific manner: the Framingham Study. JM Ordovas D Corella LA Cupples S Demissie A Kelleher O Coltell PW Wilson EJ Schaefer K Tucker, The American Journal of Clinical Nutrition 2002 75 38 46 11756058
98. Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arteriosclerosis. ES Tai S Demissie LA Cupples D Cerella PW Wilson EJ Schaefer JM Ordovas, Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 805 810 10.1161/01.ATV.0000012302.11991.42 12006394
99. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. M Ghoussaini D Meyre S Lobbens G Charpentier K Clement MA Charles M Tauber J Weill P Froguel, BMC Medical Genetics 2005 6 11 15784141 10.1186/1471-2350-6-11
100. Sodium-depedent ascorbic acid transporter family SLC23. H Takanaga B Mackenzie MA Hediger, Pflugers Archiv: European Journal of Physiology 2004 447 677 682 10.1007/s00424-003-1104-1 12845532
101. Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. P Eck HC Erichsen JG Taylor M Yeager AL Hughes M Levine SJ Chanock, Human Genetics 2004 115 285 294 10.1007/s00439-004-1167-x 15316768
102. The SOD2 Val/Val genotype enhances the risk of non-small cell lung carcinoma by p53 and XRCC1 polymorphisms. G Liu W Zhou S Park LI Wang DP Miller JC Wain TJ Lynch L Su DC Christiani, Cancer 2004 101 2802 2808 10.1002/cncr.20716 15534883
103. Polymorphism in the SOD2 and HLA-DRB1 genes are associated with non-familial idiopathic dilated cardiomyopathy in Japanese. S Hiroi H Harada H Nishi M Satoh R Nagai A Kimura, Biochemical and Biophysical Research Communications 1999 261 332 339 10.1006/bbrc.1999.1036 10425186
104. Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1. EV Zotova DA Chistiakov KV Savostianov TR Bursa IV Gallev IA Strokov VV Nosikov, Molekuliarnaia Biologiia 2003 37 404 408 12815947
105. SOD2 polymorphisms: unmasking the effects of polymorphism on splicing. J Shao L Chen B Marrs L Lee H Huang KG Manton GM Martin J Oshima, BMC Medical Genetics 2007 8 7 17331249 10.1186/1471-2350-8-7
106. Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study. J Stessman Y Maaravi R Hammerman-Rozenberg A Cohen L Nemanov I Gritsenko N Gruberman RP Ebstein, Mechanisms of Ageing and Development 2005 126 333 339 10.1016/j.mad.2004.08.025 15621215
107. Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase I locus (3p21) in Asian populations. CB Foster K Aswath SJ Chanock HF McKay U Peters, BMC Genetics 2006 7 56 75 17156480 10.1186/1471-2156-7-56
108. Toll-like receptor 4 polymorphisms and atherogenesis. S Kiechl E Lorenz M Reindl CJ Wiedermann F Oberhollenzer E Bonora J Willeit DA Schwartz, New England Journal of Medicine 2002 347 185 192 10.1056/NEJMoa012673 12124407
109. Genetic interactions with diet influence the risk of cardiovascular disease. JM Ordovas, The American Journal of Clinical Nutrition 2006 83 443S 446S 16470010
110. Conjugated linoleic acid and atherosclerosis in rabbits. KN Lee D Kritchevsky MW Pariza, Atherosclerosis 1994 108 19 25 10.1016/0021-9150(94) 90034-5 7980704
111. Antimutagenic and some other effects of conjugated linoleic acid. D Kritchevsky, The British Journal of Nutrition 2000 83 459 465 10953669
112. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. JS Munday KG Thompson KA James, The British Journal of Nutrition 1999 81 251 255 10434852
113. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. JM Arbones-Mainar MA Navarro MA Guzman C Arnal JC Surra S Acin R Carnicer J Osada HM Roche, Atherosclerosis 2006 189 318 327 10.1016/j.atherosclerosis.2006.01.015 16530768
114. Divergent mechanisms pf cis9, trans11- and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach. B De Roos G Rucklidge M Reid K Ross G Duncan MA Navarro JM Arbone-Mainar MA Gusman-Gacia J Osada J Browne CE Loscher HM Roche, FASEB Journal 2005 19 1746 1748 16055499
115. The cis-9, trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but doees not suppress aortic atherosclerosis in diabetic apoE-deficient mice. P Nestel A Fujii T Allen, Atherosclerosis 2006 189 282 287 10.1016/j.atherosclerosis.2005. 12.020 16473358
116. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholestrolemic hamsters. RJ Nicolosi EJ Roger E Kritschevsky JA Scimeca PJ Huth, Artery 1997 22 266 277 9209699
117. Conjuaged linoleic acid reduces early aortic atherosclerosis greater than linoleic in hypercholesterolemic hamsters. TA Wilson RJ Nicolosi M Chrysam D Kritchevsky, Nutrition Research 2000 20 1795 1805 10.1016/S0271-5317(00)00268-2
118. Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian Golden hamster. PL Mitchell MA Langille DL Currie RS McLeod, Biochemica et Biophysica Acta 2005 1734 269 276 15919237
119. Conjugated linoleic acid isomers reduce blood cholesterol levels but not aortic cholesterol accumulation in hypercholesterolemic hamsters. TANRJ Wilson A Saati T Kotyla D Kritchevsky, Lipids 2006 41 41 48 10.1007/s11745-006-5068-8 16555470
120. Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. V Navarro A Zabala MT Macarulla A Fernandez-Quintela VM Rodriguez E Simon MP Portillo, Journal of Physiology and Biochemistry 2003 59 193 199
121. A cis-9, trans-11 conjugated linoleic aicd-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. K Valeille J Ferezou G Amsler A Quignard-Boulange M Parquet D Gripois V Dorovska-Taran JC Martin, American Journal of Physiology Heart and Circulatory Physiology 2005 289 H652 659 10.1152/ajpheart.00130.2005 15778275
122. The natural concentration of the conjugated linoleic acid, cis-9, trans-11 in milk fat has antiatherogenic effects in hyperlipidemic hamsters. K Valeille J Ferezou M Parquet G Amsler D Gripois A Quignard-Boulange JC Martin, Journal of Nutrition 2006 136 1305 1310 16614421
123. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. I Staprans XM Pan JH Rapp KR Feingold, Molecular Nutrition and Food Research 2005 49 1075 1082 10.1002/mnfr.200500063 16270280
124. Investigation of the poteitial of conjugated linoleic acid (CLA) to cause peroxisome proliferation in rats. PA Jones LJ Lea RU Pendlington, Food and Chemical Toxicology 1999 37 1119 1125 10.1016/S0278-6915(99)00099-X 10566884
125. Conjugated linoleic acid activates peroxisome prolifeator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. SY Moya-Camarena JP Vanden Heuvel MA Belury, Biochemica et Biophysica Acta 1999 1436 331 342
126. Dietary trans10, cis 12-conjugated linoleic aicd reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. R Rasooly DS Kelley J Greg BE Mackey, The British Journal of Nutrition 2007 97 58 66 10.1017/S0007114507257745 17217560
127. Visfatin, an adipocytokine with proinflammatory and immunomudulating properties. AR Moschen AEB Kaser B Mosheimer M Theurl H Niederegger H Tilg, Journal of Immunology 2007 178 1748 1758
128. Combine effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. LF Liu A Purushotham AA Wendel MA Belury, American Journal of Physiology Gastrointestinal and Liver Physiology 2007 292 G1671 1682 10.1152/ajpgi.00523. 2006 17322064
129. Effects of conjugated linoleic acid and troglitazone on lipid accumulation and composition in lean and Zucker diabetic fatty (fa/fa) rats. AA Wendel MA Belury, Lipids 2006 41 241 247 10.1007/s11745-006-5093-7 16711598
130. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats. A Purushotham GE Shrode AA Wendel LF Liu MA Belury, Journal of Nutritional Biochemistry 2007 18 676 684 10.1016/j.jnutbio. 2006.10.008 17368879
131. Comparative Genomics and the Evolution of Animal Diversity. JD Watson TA Baker SP Bell A Gann M Levine R Losick, Molecular Biology of the Gene San Francisco, USA: Benjamin Cummings CSHL Press, Watson JD, Baker TA, Bell SP, et al, 5 2004 613 641
132. Conjugated linoleic acid - a new weapon in the battle of the bulge? C Kelly, Nutrition Bulletin 2001 26 9 10 10.1046/j.1467-3010.2001.00101.x
133. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. LD Whigham M O'Shea IC Mohede HP Walaski RL Atkinson, Food and Chemical Toxicology 2004 42 1701 1709 10.1016/j.fct.2004.06.008 15354322
134. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. JM Gaullier J Halse K Hoye K Kristiansen H Fagertun H Vik O Gudmundsen, The American Journal of Clinical Nutrition 2004 79 1118 1125 15159244
135. Supplementation with conjugated linoleic acid for 24 month is well tolerated by and reduces body fat mass in healthy, overweight human. JM Gaullier J Halse K Hoye K Kristiansen H Fagertun H Vik O Gudmundsen, Journal of Nutrition 2005 135 778 784 15795434
136. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. TM Larsen S Toubro O Gudmundsen A Astrup, The American Journal of Clinical Nutrition 2006 83 322 327
137. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. JM Gaullier J Halse HO Hoivik K Hoye C Syvertsen M Nurminiemi C Hassfeld A Einerhand M O'Shea O Gudmundsen, The British Journal of Nutrition 2007 97 550 560 10.1017/S0007114507381324 17313718
138. Conjugated linoliec aicd supplementation for twelve weeks increases lean body mass in obese humans. SE Steck AM Chalecki P Miller J Conway GL Austin JW Hardin CD Albright P Thullier, Journal of Nutrition 2007 137 1188 1193 17449580
139. Effects of CLA supplementation on immune function in young healthy volunteers. HJ Song I Grant D Rotondo I Mehede N Sattar SD Heys KW Wahle, European Journal of Clinical Nutrition 2005 59 508 517 10.1038/sj.ejcn.1602102 15674307
140. Conjugated linoleic acid supplementation reduces peripheral blood mononuclear cell interleukin-2 production in healthy middle-aged males. A Mullen F Moloney AP Nugent L Doyle KD Cashman HM Roche, Journal of Nutritional Biochemistry 2007 8 658 666 10.1016/j.jnutbio.2006.12.008
141. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. F Moloney TP Yeow A Mullen JJ Nolan HM Roche, The American Journal of Clinical Nutrition 2004 80 887 895 15447895
142. Conjugated linoleic acid supplementation in humans-metabolic effects. A Smedman B Vessby, Lipids 2001 36 773 780 10.1007/s11745-001-0784-7 11592727
143. Conjugated linoleic acid - the effect of supplementation on plasma lipid metabolism. E Noone AP Nugent HM Roche MJ Gibney, Proceedings of the Nutrition Society 2001 60 46A
144. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. S Tricon GC Burdge S Kew T Banerjee JJ Russell EL Jones RF Grimble CM Williams P Yaqoob PC Calader, he American Journal of Clinical Nutrition 2004 80 T614 620
145. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. S Tricon GC Burdge S Kew T Banerjee JJ Russell RF Grimble CM Williams PC Calder P Yaqoob, he American Journal of Clinical Nutrition 2004 80 1626 1633 15585778
146. Supplemetation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. U Riserus B Vessby P Arner B Zethelius, Diabetologia 2004 47 1016 1019 10.1007/s00125-004-1421-8 15168020
147. Supplementation with Conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. U Riserus S Basu S Jovinge GN Fredrikson J Arnlov B Vessby, Circulation 2002 106 1925 1929 10.1161/01.CIR.0000033589.15413. 48 12370214
148. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxigenase-2 inhibitor. A Smedman B Vessby S Basu, Clinical Science (London, England) 2004 106 67 73
149. Conjugated linoleic acid impairs endothelial function. JS Taylor SR Williams R Rhys P James MP Frenneaux, Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 307 312 10.1161/01.ATV.0000199679.40501.ac 16339498
150. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. LDWAC Whigham DA Schoeller, The American Journal of Clinical Nutrition 2007 85 1203 1211 17490954
151. Clinical trials results support preference for using CLA preparations enriched woth tpw isomers rather than four isomers in human studies. JM Gaullier G Berven H Blankson O Gudmundsen, Lipids 2002 37 1019 1025 10.1007/s11745-002- 0995-y 12558050
152. Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Y Li BA Watkins, Lipids 1998 33 417 425 10.1007/s11745-998-0223-9 9590630
153. Linoleic acid partially restores the triglyceride content of conjugated linoleic acid-treated cultures of 3T3-L1 preadipocytes. M Brown M Evans M McIntosh, Journal of Nutritional Biochemistry 2001 12 381 387 10.1016/S0955-2863(01)00152-8 11448613
154. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter: 1. Identification of the protein and delineation of its target nucleotide sequence. MR Briggs C Yokoyama X Wang MS Brown JL Goldstein, Journal of Biological Chemistry 1993 268 14490 14496 8390995
155. LDL receptor gene transcription is selectively induced by t10c12-CLA but not by c911t-CLA in the human hepetoma cell line HepG2. R Ringseis B Konig B Leuner S Schubert N Nass G Stangl K Eder, Biochemica et Biophysica Acta 2006 1761 1235 1243
156. Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells. S Yu-Poth D Yin G Zhao PM Kris-Etherton TD Etherton, Journal of Nutrition 2004 134 68 71 14704295
157. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Y Iwakiri DA Sampson KG Allen, Prostaglandins, Leukotrienes, and Essential Fatty Acid 2002 67 435 443 10.1054/plef.2002.0454 12468265
158. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelet. AP Torres-Duarte JY Vanderhoek, Biochemica et Biophysica Acta 2003 1640 69 76 12676356
159. Decreased production of inflammatory mediators in human osteoarthritic chondrocytes by conjugated linoleic acids. CL Shen DM Dunn JH Henry Y Li BA Watkins, Lipids 2004 39 161 166 15134143
160. CLA isomers inhibit TNFalpha-induced eicosanoid release from human vascular smooth muscle cells via a PPARgamma ligand-like action. R Ringseis A Muller C Herter S Gahler H Steinhart K Eder, Biochemica et Biophysica Acta 2006 1760 290 300
161. Failure of conjugated linoleic acid supplementation to enhance biosynthesis of docosahexaenoic acid from alpha-linoleic acid in healthy human volunteers. NM Attar-Bashi RS Weisingers DP Begg D Li AJ Sinclair, Prostaglandins, Leukotrienes, and Essential Fatty Acids 2007 76 121 130 10.1016/j.plefa.2006.11.002 17275274
162. Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma. CP Alibin MA Kopilas HD Anderson, Journal of Biological Chemistry 2008 283 10707 10715 10.1074/jbc.M800035200 18283099
163. Conjugated linoleic acid prevents the development of essential hypertension in spontaneously hypertensive rats. N Inoue K Nagao J Hirata YM Wang T Yanagita, Biochemical and Biophysical Research Communications 2004 323 679 684 10.1016/j.bbrc.2004.08.139 15369804
164. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. K Nagao N Inoue YM Wang T Yanagita, Biochemical and Biophysical Research Communications 2003 310 562 566 10.1016/j.bbrc.2003.09.044 14521947
165. The 10trans, 12 cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. K Nagao N Inoue YM Wang J Hirata Y Shimada T Nagao T Matsui T Yanagita, Biochemical and Biophysical Research Communications 2003 306 134 138 10.1016/S0006-291X(03) 00929-X
166. Diets rich in conjugated linoleic acid and vaccenic acid have no effect on blood pressure and isobaric arterial elasticity in healthy young men. M Raff T Tholstrup K Sejrsen EM Straarup N Wiinberg, Journal of Nutrition 2006 136 992 997 16549463